{rfName}
Li

Indexed in

License and use

Citations

25

Altmetrics

Analysis of institutional authors

Fondevila, ConstantinoAuthor

Share

March 29, 2023
Publications
>
Review
No

Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT

Publicated to:Journal of Clinical Medicine. 10 (10): - 2021-05-01 10(10), DOI: 10.3390/jcm10102131

Authors: Molla, Meritxell; Fernandez-Plana, Julen; Albiol, Santiago; Fondevila, Constantino; Vollmer, Ivan; Cases, Carla; Garcia-Criado, Angeles; Capdevila, Jaume; Conill, Carles; Fundora, Yliam; Fernandez-Martos, Carlos; Pineda, Estela;

Affiliations

August Pi i Sunyer Biomed Res Inst IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumors, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Dept Gen & Digest Surg, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Dept Med Oncol, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Dept Radiat Oncol, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Dept Radiol, Barcelona 08036, Spain - Author
Hosp Mutua Terrassa, Dept Med Oncol, Terrassa 08221, Spain - Author
Inst Valenciano Oncol, Dept Med Oncol, Valencia 46009, Spain - Author
Univ Autonoma Barcelona, Vall DHebron Univ Hosp, Dept Med Oncol, Barcelona 08035, Spain - Author
See more

Abstract

The prognosis for oligometastatic colorectal cancer has improved in recent years, mostly because of recent advances in new techniques and approaches to the treatment of oligometastases, including new surgical procedures, better systemic treatments, percutaneous ablation, and stereotactic body radiation therapy (SBRT). There are several factors to consider when deciding on the better approach for each patient: tumor factors (metachronous or synchronous metastases, RAS mutation, BRAF mutation, disease-free interval, size and number of metastases), patient factors (age, frailty, comorbidities, patient preferences), and physicians' factors (local expertise). These advances have presented major challenges and opportunities for oncologic multidisciplinary teams to treat patients with limited liver and lung metastases from colorectal cancer with a curative intention. In this review, we describe the different treatment options in patients with limited liver and lung metastases from colorectal cancer, and the possible combination of three approaches: systemic treatment, surgery, and local ablative treatments.

Keywords

ablationcolorectal cancerliver metastaseslung metastasesoligometastasisAblationColorectal cancerHepatic arterial infusionLiver metastasesLung metastasesMicrowave ablationNeoadjuvant chemotherapyOligometastasisPercutaneous radiofrequency ablationPhase-iiiPlus bevacizumabPulmonary metastasesRadiation-therapyStereotactic body radiation therapyStereotactic body radiotherapyThermal ablation

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Journal of Clinical Medicine due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Medicine (Miscellaneous).

From a relative perspective, and based on the normalized impact indicator calculated from World Citations from Scopus Elsevier, it yields a value for the Field-Weighted Citation Impact from the Scopus agency: 1.35, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 6.46 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-08, the following number of citations:

  • WoS: 9
  • Scopus: 12

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-08:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 33.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 36 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 2.7.
  • The number of mentions on the social network X (formerly Twitter): 5 (Altmetric).